Skip to main content
Premium Trial:

Request an Annual Quote

PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study

NEW YORK – Immune disease prognostic firm PredictImmune announced on Thursday a collaboration with the Crohn's & Colitis Foundation to validate the company's PredictSure IBD test in a diverse patient population.

The Predicting Crohn's and Colitis Outcomes in the United States (PRECIOUS) study will track up to 200 patients from 15 medical centers across the US with Crohn's disease or ulcerative colitis who aren't receiving systemic steroids, immunomodulators, or biologics. The first patients, who will be monitored for up to a year, have been recruited by New York University/Bellevue hospital, the company said.

Patients will be sorted into high-risk and low-risk cohorts using the PredictSure IBD test, which stratifies patients based on the risk of experiencing a severe disease course requiring multiple escalations in treatment.

"Personalized therapy is key to optimizing outcomes and minimizing risks for our patients with IBD," Lea Ann Chen, the study's principal investigator, said in a statement. "It is also dependent on having accurate predictors of disease behavior."

PredictImmune and the foundation are jointly funding the study.

Cambridge, UK-based PredictImmune announced last month its partnership with KSL Biomedical to promote and provide the PredictSure IBD test in North America.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.